BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 25681004)

  • 1. Brain-derived neurotrophic factor (BDNF) and neurocognitive deficits in people with schizophrenia: a meta-analysis.
    Ahmed AO; Mantini AM; Fridberg DJ; Buckley PF
    Psychiatry Res; 2015 Mar; 226(1):1-13. PubMed ID: 25681004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers.
    Ho BC; Milev P; O'Leary DS; Librant A; Andreasen NC; Wassink TH
    Arch Gen Psychiatry; 2006 Jul; 63(7):731-40. PubMed ID: 16818862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prefrontal cognition in schizophrenia and bipolar illness in relation to Val66Met polymorphism of the brain-derived neurotrophic factor gene.
    Rybakowski JK; Borkowska A; Skibinska M; Szczepankiewicz A; Kapelski P; Leszczynska-Rodziewicz A; Czerski PM; Hauser J
    Psychiatry Clin Neurosci; 2006 Feb; 60(1):70-6. PubMed ID: 16472361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Meta-Analysis of Brain-Derived Neurotrophic Factor Effects on Brain Volume in Schizophrenia: Genotype and Serum Levels.
    Ahmed AO; Kramer S; Hofman N; Flynn J; Hansen M; Martin V; Pillai A; Buckley PF
    Neuropsychobiology; 2021; 80(5):411-424. PubMed ID: 33706323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of the brain-derived neurotrophic factor Val66Met polymorphism with negative symptoms severity, but not cognitive function, in first-episode schizophrenia spectrum disorders.
    Mezquida G; Penadés R; Cabrera B; Savulich G; Lobo A; González-Pinto A; Penzol MJ; Corripio I; Fernandez-Egea E; Gassó P; Cuesta MJ; Bernardo M;
    Eur Psychiatry; 2016 Oct; 38():61-69. PubMed ID: 27668551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association among aggressiveness, neurocognitive function, and the Val66Met polymorphism of brain-derived neurotrophic factor gene in male schizophrenic patients.
    Chung S; Chung HY; Jung J; Chang JK; Hong JP
    Compr Psychiatry; 2010; 51(4):367-72. PubMed ID: 20579509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of brain-derived neurotrophic factor genetic polymorphism on cognition: A systematic review.
    Toh YL; Ng T; Tan M; Tan A; Chan A
    Brain Behav; 2018 Jul; 8(7):e01009. PubMed ID: 29858545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive and serum BDNF correlates of BDNF Val66Met gene polymorphism in patients with schizophrenia and normal controls.
    Zhang XY; Chen DC; Xiu MH; Haile CN; Luo X; Xu K; Zhang HP; Zuo L; Zhang Z; Zhang X; Kosten TA; Kosten TR
    Hum Genet; 2012 Jul; 131(7):1187-95. PubMed ID: 22362486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smoking and BDNF Val66Met polymorphism in male schizophrenia: a case-control study.
    Zhang XY; Chen DC; Tan YL; Luo X; Zuo L; Lv MH; Shah NN; Zunta-Soares GB; Soares JC
    J Psychiatr Res; 2015 Jan; 60():49-55. PubMed ID: 25455509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Traumatic experiences and cognitive profiles of schizophrenia cases influenced by the BDNF Val66met polymorphism.
    Veras AB; Chao MV; Getz M; Goetz R; Cheniaux E; Lopes FL; Nardi AE; Walsh-Messinger J; Malaspina D; Kranz TM
    Psychiatry Res; 2019 Jan; 271():111-113. PubMed ID: 30472504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A role for the BDNF gene Val66Met polymorphism in schizophrenia? A comprehensive review.
    Notaras M; Hill R; van den Buuse M
    Neurosci Biobehav Rev; 2015 Apr; 51():15-30. PubMed ID: 25562189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Association study of brain-derived neurotrophic factor Val66Met polymorphism and clinical characteristics of first episode schizophrenia].
    Sun MM; Liu LF; Yang LM; Wang Y; Cui KY; Wang LN; Li CL; Qiao DD; Wang RZ
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Apr; 29(2):155-8. PubMed ID: 22487823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BDNF val66met genotype and schizotypal personality traits interact to influence probabilistic association learning.
    Skilleter AJ; Weickert CS; Moustafa AA; Gendy R; Chan M; Arifin N; Mitchell PB; Weickert TW
    Behav Brain Res; 2014 Nov; 274():137-42. PubMed ID: 25125238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain-Derived Neurotrophic Factor Gene Val66Met Polymorphism and Risk of Schizophrenia: A Meta-analysis of Case-Control Studies.
    Kheirollahi M; Kazemi E; Ashouri S
    Cell Mol Neurobiol; 2016 Jan; 36(1):1-10. PubMed ID: 26134309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Val66Met functional polymorphism and serum protein level of brain-derived neurotrophic factor (BDNF) in acute episode of schizophrenia and depression.
    Skibinska M; Groszewska A; Kapelski P; Rajewska-Rager A; Pawlak J; Dmitrzak-Weglarz M; Szczepankiewicz A; Twarowska-Hauser J
    Pharmacol Rep; 2018 Feb; 70(1):55-59. PubMed ID: 29331787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BDNF Val66Met polymorphism and hippocampal volume in neuropsychiatric disorders: A systematic review and meta-analysis.
    Harrisberger F; Smieskova R; Schmidt A; Lenz C; Walter A; Wittfeld K; Grabe HJ; Lang UE; Fusar-Poli P; Borgwardt S
    Neurosci Biobehav Rev; 2015 Aug; 55():107-18. PubMed ID: 25956254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain derived neurotrophic factor Val66Met polymorphism and psychotic symptoms in Alzheimer's disease.
    Pivac N; Nikolac M; Nedic G; Mustapic M; Borovecki F; Hajnsek S; Presecki P; Pavlovic M; Mimica N; Muck Seler D
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):356-62. PubMed ID: 21044653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain-derived neurotrophic factor Val66Met polymorphism and obsessive-compulsive symptoms in Egyptian schizophrenia patients.
    Hashim HM; Fawzy N; Fawzi MM; Karam RA
    J Psychiatr Res; 2012 Jun; 46(6):762-6. PubMed ID: 22521161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain-derived neurotrophic factor genetic polymorphism (rs6265) is protective against chemotherapy-associated cognitive impairment in patients with early-stage breast cancer.
    Ng T; Teo SM; Yeo HL; Shwe M; Gan YX; Cheung YT; Foo KM; Cham MT; Lee JA; Tan YP; Fan G; Yong WS; Preetha M; Loh WJ; Koo SL; Jain A; Lee GE; Wong M; Dent R; Yap YS; Ng R; Khor CC; Ho HK; Chan A
    Neuro Oncol; 2016 Feb; 18(2):244-51. PubMed ID: 26289590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hippocampal volume and the brain-derived neurotrophic factor Val66Met polymorphism in first episode psychosis.
    Smith GN; Thornton AE; Lang DJ; Macewan GW; Ehmann TS; Kopala LC; Tee K; Shiau G; Voineskos AN; Kennedy JL; Honer WG
    Schizophr Res; 2012 Feb; 134(2-3):253-9. PubMed ID: 22192502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.